Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study

Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study

ObjectiveHypogonadism is common in male patients with adrenocortical carcinoma (ACC) who are under treatment with mitotane, but the phenomenon is underestimated, and its prevalence has been poorly studied. This single-center retrospective longitudinal study was undertaken to assess the frequency of...

Full description

Bibliographic Details
Main Authors: Andrea Delbarba, Deborah Cosentini, Paolo Facondo, Marta Laganà, Letizia Chiara Pezzaioli, Valentina Cremaschi, Andrea Alberti, Salvatore Grisanti, Carlo Cappelli, Alberto Ferlin, Alfredo Berruti
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Endocrinology
Subjects:
adrenal tumor
mitotane
androgens
hypogonadism
testosterone
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1128061/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1128061/full

Similar Items